REQUEST A DEMO
Total
USD $0.00
Search more companies

Bitrial Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: BITRIAL Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

BiTrial Kft. is a mid-sized Clinical Research Organization (CRO) specializing in medical devices and offers a full range of services to pharmaceutical, biotechnology, and medical equipment companies, as well as global CRA companies in phase I-IV medicine and promotion of medical tools. With over 20 years of experience, they provide extensive expertise for conducting clinical trials for both manufacturers of medical devices and pharmaceutical companies in the Central-Eastern European Region. They are a charter member of the first Hungarian Clinical Trial Cluster (HCTC).

Headquarters
Tallya utca 23.
Budapest; Budapest; Postal Code: 1121

Contact Details: Purchase the Bitrial Kft. report to view the information.

Website: http://www.bitrial.hu

Basic Information
Total Employees:
Purchase the Bitrial Kft. report to view the information.
Outstanding Shares:
Purchase the Bitrial Kft. report to view the information.
Registered Capital:
Purchase the Bitrial Kft. report to view the information.
Financial Auditors:
Purchase the Bitrial Kft. report to view the information.
Incorporation Date:
June 17, 2005
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bitrial Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
31.89%
Total operating revenue
31.03%
Operating profit (EBIT)
20.24%
EBITDA
19.78%
Net Profit (Loss) for the Period
9.97%
Total assets
-13.33%
Total equity
-16.66%
Operating Profit Margin (ROS)
-1.43%
Net Profit Margin
-2.93%
Return on Equity (ROE)
5.96%
Quick Ratio
-0.09%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?